Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Reversible Cerebral Vasoconstriction Syndrome's Precipitating Factors. Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome

NCT04179383 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04179383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04179383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Reversible Cerebral Vasoconstriction Syndrome's Precipitating Factors. Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Unknown status
Start date
December 5, 2019
Completion date
September 30, 2024
Enrollment
225 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

reversible cerebral vasoconstriction syndrome